eGenesis is a startup based in the United States, 4 tracked investors.
eGenesis is a company headquartered in the United States. Brouky records 4 investors associated with the company.
eGenesis is a biotechnology company utilizing multiplex gene editing and genome engineering to develop human-compatible organs through xenotransplantation, aiming to eliminate organ transplant waitlists.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.